Concord Drugs Ltd - 538965 - Closure of Trading Window
Closure of trading window for the quarter ended 31.12.202227-12-2022
27-12-2022
Concord Drugs Ltd - 538965 - Disclosure Of Related Party Transactions Under Regulation 23(9) Of SEBI (LODR) Regulations, 2015 For The Half Year Ended 30.09.2022
Disclosure of Related Party Transactions under Regulation 23(9) of SEBI (LODR) Regulations, 2015 for the half year ended 30.09.202228-11-2022
Concord Drugs Ltd - 538965 - Outcome Of Board Meeting Held On 14.11.2022
Outcome of Board Meeting held on 14.11.202214-11-2022
Concord Drugs Ltd - 538965 - Announcement under Regulation 30 (LODR)-Cessation
Cessation of Company Secretary and Compliance Officer11-11-2022
Concord Drugs Ltd - 538965 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for S Nagi Reddy & PACs09-11-2022
Concord Drugs Ltd - 538965 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for S Manoj Kumar Reddy & PACs09-11-2022
Concord Drugs Ltd - 538965 - Outcome Of Board Meeting Held On 07.11.2022
Outcome of Board Meeting held on 07.11.202207-11-2022
Concord Drugs Ltd - 538965 - Appointment of Company Secretary and Compliance Officer
Appointment of Company Secretary and Compliance Officer04-11-2022
Concord Drugs Ltd - 538965 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 14.11.2022
Concord Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2022 ,inter alia, to consider and approve Intimation of board meeting to be held on 14.11.202203-11-2022
Concord Drugs Ltd - 538965 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Reg 74 (5)19-10-2022